✦ LIBER ✦

Overexpression of p53 and prognosis in breast cancer

✍ Scribed by Kay Friedrichs; Saskia Gluba; Holger Eidtmann; Walter Jonat

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 649 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19931215)72:12<3641::aid-cncr2820721215>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FAK overexpression and p53 mutations are

FAK overexpression and p53 mutations are highly correlated in human breast cancer

✍ Vita M. Golubovskaya; Kathleen Conway-Dorsey; Sharon N. Edmiston; Chiu-Kit Tse; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 135 KB

## Abstract Focal adhesion kinase (FAK) is overexpressed in a number of tumors, including breast cancer. Another marker of breast cancer tumorigenesis is the tumor suppressor gene __p53__ that is frequently mutated in breast cancer. In the present study, our aim was to find a correlation between FA

Relationship between p53 gene abnormalit

Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis

✍ Ram Seshadri; Anthony S.-Y. Leong; Kieran McCaul; Frank A. Firgaira; Vittal Setl 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 757 KB

The prognostic significance of p53 gene abnormalities was investigated in 9 I9 primary breast-cancer patients. p53 expression and tumour-cell proliferation fraction determined by MIB-I count, p53 exon 5 and 6 mutations and HER-Z/neu oncogene amplification were detected by immunohistochemistry, PCR-S

c-erbB-2 protein overexpression and p53

c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

✍ Shimizu, Chikako; Fukutomi, Takashi; Tsuda, Hitoshi; Akashi-Tanaka, Sadako; Wata 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

Background and Objectives: We investigated whether expression levels of c-erbB-2 and p53 proteins in breast cancer tissues differ in primary and metastatic lesions. Methods: Immunohistochemical staining or sandwich enzyme immunoassay was used to determine expression levels of c-erbB-2 and p53 protei

Parity and prognosis in breast cancer

✍ Angelos E. Papatestas; Dr Michael Mulvihill; Catherine Josi; John Ioannovich; Ge 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

Analysis of five-year disease-free survival rates in 608 women with operable breast cancer revealed that the reproductive history is a significant prognostic determinant. Overall parous women had a significantly higher cumulative five-year disease-free survival rate (a%), compared to the nulliparous

The p53 positive Bcl-2 negative phenotyp

The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer

✍ Phil Rolland; Ian Spendlove; Zahra Madjid; Emad A. Rakha; Poulam Patel; Ian O. E 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 275 KB

## Abstract The purpose of this work was to determine if the immunohistochemical p53 (+) Bcl‐2 (−) phenotype predicts survival in breast cancer patients. Tissue from 819 cases of resected primary breast cancer, presented between 1986 and 1998, were assembled in tissue microarray format. Clinicopath

Mutations of the p53 gene in male breast

Mutations of the p53 gene in male breast cancer

✍ Agnaldo Anelli; Tǎnia F. M. Anelli; Bruce Youngson; Paul P. Rosen; Patrick I. Bo 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 609 KB